After coronavirus, next pandemic may come crawling from the melting glaciers
Once again study recommends that the following viral pandemic might rise out of the Cold in the midst of dissolving ice ...
A Covid-19 vaccine may be rolled out by March 2021 to the most vulnerable, which along with other advances could fundamentally change the course of the pandemic, a senior World Health Organization (WHO) official said on Monday.Bruce Aylward also told the WHO’s annual ministerial assembly that interim results announced from Pfizer Inc’s late-stage vaccine trials were “very positiveâ€.“There is still much work to be done, this is just interim results...but some very positive results coming today which should hold great promise hopefully for the entire world as we move forward,†Aylward told the 194-member state forum.Pfizer said its experimental Covid-19 vaccine with partner BioNTech was more than 90% effective.WHO Director-General Tedros Adhanom Ghebreyesus tweeted shortly afterwards: “We welcome the encouraging vaccine news from @pfizer & @BioNTech_Group & salute all scientists & partners around the who are developing new safe, efficacious tools to beat #Covid19.’Aylward, referring to all three pillars of the ACT (Access to Covid Tools) Accelerator launched in April, said: “In diagnostics we are in a position to massively expand testing globally, in therapeutics we have sufficient tools right now to substantially reduce the risk of dying from this disease and in the area of vaccines - with the news of today especially - we are on the verge of having the readiness in place to roll out doses for high-risk populations in the late first quarter, early 2nd quarter.â€However, he warned that an “acute funding gap†of $4.5 billion could slow access to tests, medicines and vaccines in low- and middle-income countries.
View SourceThis notice has been removed
The content is no longer available
A Covid-19 vaccine may be rolled out by March 2021 to the most vulnerable, which along with other advances could fundamentally change the course of the pandemic, a senior World Health Organization (WHO) official said on Monday.Bruce Aylward also told the WHO’s annual ministerial assembly that interim results announced from Pfizer Inc’s late-stage vaccine trials were “very positiveâ€.“There is still much work to be done, this is just interim results...but some very positive results coming today which should hold great promise hopefully for the entire world as we move forward,†Aylward told the 194-member state forum.Pfizer said its experimental Covid-19 vaccine with partner BioNTech was more than 90% effective.WHO Director-General Tedros Adhanom Ghebreyesus tweeted shortly afterwards: “We welcome the encouraging vaccine news from @pfizer & @BioNTech_Group & salute all scientists & partners around the who are developing new safe, efficacious tools to beat #Covid19.’Aylward, referring to all three pillars of the ACT (Access to Covid Tools) Accelerator launched in April, said: “In diagnostics we are in a position to massively expand testing globally, in therapeutics we have sufficient tools right now to substantially reduce the risk of dying from this disease and in the area of vaccines - with the news of today especially - we are on the verge of having the readiness in place to roll out doses for high-risk populations in the late first quarter, early 2nd quarter.â€However, he warned that an “acute funding gap†of $4.5 billion could slow access to tests, medicines and vaccines in low- and middle-income countries.
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Sign in to continue to Global Noticeboard
Enter your email to receive a reset link
Create a new password for your account
You are marking this Notice are inappropriate, and you belive it infringes on the Global Noticeboard Community Guidelines (link). Is this so?
Create 3 Noticeboards to earn this Silver level Community Champion Badge.
View all badges that you can earnPlease tell us why you are reporting this content.
Discussion (0)
No comments yet